Universitätsklinikum Heidelberg

Hospital


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000103284908

ROR: https://ror.org/013czdx64

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Recommendations regarding the evaluation of a reduction in earning capacity for occupational skin cancer Minderung der Erwerbsfähigkeit bei arbeitsbedingten Hautkrebserkrankungen (2017) Diepgen TL, Bauer A, Bernhard-Klimt C, Elsner P, Drexler H, Fartasch M, John SM, et al. Journal article, Review article Adiabatically prepared spin-lock approach for T1ρ-based dynamic glucose enhanced MRI at ultrahigh fields (2017) Schuenke P, Koehler C, Korzowski A, Windschuh J, Bachert P, Ladd ME, Mundiyanapurath S, et al. Journal article, Original article ECG-based 4D-dose reconstruction of cardiac arrhythmia ablation with carbon ion beams: application in a porcine model (2017) Richter D, Lehmann HI, Eichhorn A, Constantinescu AM, Kaderka R, Prall M, Lugenbiel P, et al. Journal article Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients (2017) Hartkopf AD, Graf J, Simoes E, Keilmann L, Sickenberger N, Gaß P, Wallwiener D, et al. Journal article Real world effectiveness and safety of pazopanib and everolimus in metastatic renal cell carcinoma: first interim analysis of the PAZOREAL study (2017) Bedke J, Welslau M, Boegemann M, Schostak M, Hering-Schubert C, Petzoldt A, Wolf T, et al. Conference contribution Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) (2017) Kuemmel S, Paepke S, Huober J, Schem C, Untch M, Blohmer JU, Eiermann W, et al. Journal article Long-term survival analysis of the randomized phase II trial investigating the addition of carboplatin to neoadjuvant therapy for triple-negative (TNBC) and HER2-positive early breast cancer (GeparSixto) (2017) Untch M, Schneeweiss A, Salat C, Rezai M, Zahm DM, Klare P, Blohmer JU, et al. Conference contribution Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial (2017) Wallwiener M, Matthies L, Simoes E, Keilmann L, Hartkopf AD, Sokolov AN, Walter CB, et al. Journal article Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications (2017) Stefanovic S, Wallwiener M, Karic U, Domschke C, Katic L, Taran FA, Pesic A, et al. Journal article Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey (2017) Klein E, Beckmann M, Bader W, Brucker C, Dobos G, Fischer D, Hanf V, et al. Journal article